ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

TRDA Entrada Therapeutics Inc

14.1504
0.1004 (0.71%)
Last Updated: 12:36:33
Delayed by 15 minutes

Entrada Therapeutics Financial Summary

The current TRDA market cap is 475.47M. The company's latest EPS is USD -0.1990 and P/E is -71.11.

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)
Total Revenue 0025.26M18.17M43.74M
Operating Income -25.94M-25.58M-5.78M-16.3M14.01M
Net Income -25.14M-24.63M-6.67M-25.93M35.46M
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Total Revenue 00129.01M
Operating Income -51.13M-97.25M-3.16M
Net Income -51.16M-94.62M-6.69M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)
Total Assets 274.46M252.06M475.57M493.98M485.03M
Total Liabilities 41.24M39.5M245.96M287.08M238.37M
Total Equity 233.22M212.55M229.61M206.91M246.66M
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Total Assets 305.83M252.06M469.19M
Total Liabilities 7.12M39.5M226.83M
Total Equity 298.72M212.55M242.36M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)
Operating -66.48M-93.79M203.4M168.31M143.82M
Investing -167.44M-148.65M-40.44M-153.7M-157.44M
Financing 121k479k19.54M19.98M20.35M
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Operating -50.86M-93.79M139.8M
Investing -4.58M-148.65M-138.4M
Financing 307.46M479k21.04M
Market Cap 475.47M
Price to Earnings Ratio -71.11
Price to Sales Ratio 3.69
Price to Cash Ratio 7.03
Price to Book Ratio 1.96
Dividend Yield -

Share Statistics

Shares Outstanding 33.6M
Average Volume (1 week) 46.64k
Average Volume (1 Month) 67.27k
52 Week Change 21.99%
52 Week High 18.44
52 Week Low 10.62
Spread (Intraday) 0.12 (0.84%)

Company Info

Company Name Entrada Therapeutics Inc
Address 1209 orange street
wilmington, delaware 19801
Website https://www.entradatx.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock